Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines
- 1 March 2001
- journal article
- Published by Elsevier in Clinical Therapeutics
- Vol. 23 (3) , 392-403
- https://doi.org/10.1016/s0149-2918(01)80044-8
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Are booster immunisations needed for lifelong hepatitis B immunity?The Lancet, 2000
- Over a decade of experience with a yeast recombinant hepatitis B vaccineVaccine, 1999
- Status of hepatitis B immunization programmes in 1998Vaccine, 1998
- Universal Hepatitis B Vaccination in Taiwan and the Incidence of Hepatocellular Carcinoma in ChildrenNew England Journal of Medicine, 1997
- Prospective analysis of the factors influencing the antibody response to hepatitis b vaccine in hemodialysis patientsAmerican Journal of Kidney Diseases, 1997
- Global programme for control of hepatitis B infectionVaccine, 1995
- The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen-positive-hepatitis B surface antigen carrier mothersThe Pediatric Infectious Disease Journal, 1991
- FOLLOW—UP OF NEWBORNS of HBsAg CARRIER MOTHERS VACCINATED WITH rec-DNA HBV VACCINEPediatric Research, 1990
- Protective efficacy of a recombinant DNA vaccine against hepatitis B in male homosexuals: results at 36 monthsVaccine, 1990
- Effects of different dose levels and vaccination schedules on immune response to a recombinant DNA hepatitis B vaccine in haemodialysis patientsVaccine, 1990